Greykasell Wealth Strategies, Inc. Novartis Ag Transaction History
Greykasell Wealth Strategies, Inc.
- $187 Billion
- Q1 2025
A detailed history of Greykasell Wealth Strategies, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Greykasell Wealth Strategies, Inc. holds 2,013 shares of NVS stock, worth $233,346. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,013Holding current value
$233,346% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,555Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$998 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$818 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$784 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...